Schedule 13G ownership disclosure

CALIDI BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 320703101

Event date: 2023-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001393825-23-000227
Form type
SC 13G/A
Filer
Calidi Biotherapeutics, Inc.
CIK
CIK 1855485
Filed
Oct 10, 2023
Reporting period
Sep 30, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub